Thrive Earlier Detection IPO

Thrive is the developer a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages.

Register for Details

For more details on financing and valuation for Thrive Earlier Detection, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Thrive Earlier Detection

Forge green plus iconForge green minus icon

What is Thrive Earlier Detection funding to date?

Thrive Earlier Detection has raised $110MM.
Forge green plus iconForge green minus icon

When was Thrive Earlier Detection founded?

Thrive Earlier Detection was founded in 2019.
Updated on: Jun 12, 2022